Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment (Johnston, et al, 2023)

13 feb.

Escrito por Michael DeMarco, therapist

Michael DeMarco, therapist

Psychedelic therapist, clinical sexologist, and Founding Fellow of Psychedelic Institute of Mental Health and Family Therapy

https://psychedelicmentalhealth.net/michael-demarco-therapist

A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties (Sumner, et al, 2021)

Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches (Batievsky, et al, 2023)